Definition and significance of polycystic ovaries

Bailliere's Clinical Obstetrics and Gynaecology

Volumn 11, Issue 2, 1997, Pages 349-368

  Dewailly, D ^a  

^a Unite de Soins Normalisee A   (France)

Author keywords

Anovulation, luteinizing hormone; Cardiovascular risk, ovarian stroma; GnRH agonist; Hyperandrogenism; Infertility; Polycystic ovaries; Ultrasonography, hyperinsulinism

Indexed keywords

ANDROGEN; GONADORELIN AGONIST; GONADOTROPIN; INSULIN;

ANDROGEN SYNTHESIS; ANOVULATION; CANCER RISK; CARDIOVASCULAR RISK; CLINICAL FEATURE; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; FEMALE FERTILITY; HISTOPATHOLOGY; HUMAN; HYPERANDROGENISM; HYPERINSULINISM; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SOCIAL PSYCHOLOGY;

EID: 0030742850     PISSN: 09503552     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3552(97)80041-7     Document Type: Article

References (67)

1. Adams J Polson DW Abulwadi N Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin-releasing hormone Lancet ii 1985 1375 1378
2. Adams J Polson DW Franks S Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism British Medical Journal 293 1986 355 359
3. OR26-2 Adams JM Taylor AE Crowley WF Jr Hall JE Polycystic ovarian morphology: significance in women with regular ovulatory cycles 10th International Congress of Endocrinology, San Francisco, USA Volume 1 1996
4. Aleem FA Predanic M Transvaginal color doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease Fertility and Sterility 65 1996 510 516
5. Ardaens Y Robert Y Lemaitre L Polycystic ovarian disease: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis Fertility and Sterility 55 1991 1062 1068
6. Azziz R Dewailly D Owerbach D Clinical Review 56. Non-classic adrenal hyperplasia: current concepts Journal of Clinical Endocrinology and Metabolism 78 1994 810 815
7. Azziz R Bradley EL Jr Potter HD Boots LR Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation Journal of Clinical Endocrinology and Metabolism 80 2 1995 400 405
8. Balen AH Tan SL Macdougall J Jacobs HS Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin Human Reproduction 8 1993 959 964
9. Bihari-Varga M Szekely J Gruber E Plasma high density lipoproteins in coronary, cerebral and peripheral vascular diseases: the influence of various risk factors Atherosclerosis 40 1981 337 345
10. Bringer J Lefebvre P Boulet F Body composition and regional fat distribution in polycystic ovarian syndrome. Relationship to hormonal and metabolic profiles Annals of the New York Academy of Science 687 1993 115 123
11. Buyalos RP Lee CT Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization Fertility and Sterility 65 1996 1 10
12. Cara JF Nongonadotrophic regulation of ovarian function: insulin Filicori M Flamigni C Ovulation Induction: Basic Science and Clinical Advances 1994 Excerpta Medica Amsterdam 65 72
13. Carmina E Koyama T Chang L Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? American Journal of Obstetrics and Gynecology 167 1992 1807 1812
14. Clayton RN Ogden V Hodgkinson J How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clinical Endocrinology 37 1992 127 134
15. Conway GS Honour JW Jacobs HS Heterogeneity of the polycystic ovary syndrome: Clinical, endocrine and ultrasound features in 556 patients Clinical Endocrinology 30 1989 459 470
16. Abstract No. 1774 Cortet-Rudelli C Devemy F Mingaux F Relationship between IGFBP-1 and androgens in the polycystic ovarian disease (PCOD) Proceedings of the Endocrine Society Anaheim, USA, June 15–18th 1994 644
17. Cortet-Rudelli C Decanter C Demarquet C Low SHBG plasma level: a marker of hyper-insulinism in adolescent girls with polycystic ovarian syndrome (PCOS) Proceedings of the 10th International Congress of Endocrinology, San Francisco, USA, June 12th–15th Volume 1 1996 P2 618
18. Dahlgren E Janson PO Johansson L Polycystic ovary syndrome and risk for myocardial infarction Acta Obstetrica Gynecologia Scandinavia 71 1992 599 604
19. Deroubaix-Allard D Cortet-Rudelli C Duhamel A Abdominal adipose tissue is the main anthropometric determinant of women's gonadal function Proceedings of the 10th International Congress of Endocrinology, San Francisco, USA, June 12th–15th Volume 1 1996 P2 621
20. Abstract No. P2-650 Dewailly C Robert Y Dewailly D The menstrual status, the LH level and the ovarian ultrasonography as predictors of polycystic ovary syndrome (PCOS) in patients with non classic 21 hydroxylase deficiency (NC-CAH) Proceedings of the 10th International Congress of Endocrinology San Francisco, USA, June 12th–15th 1996
21. Dewailly D Duhamel A Robert Y Interrelationship between ultrasonography and biology in the diagnosis of polycystic ovarian disease Annals of New York Academy of Science 687 1993 206 216
22. Dewailly D. Robert Y Helin I Ovarian stromal hypertrophy in hyperandrogenic women Clinical Endocrinology 41 1994 557 562
23. Donesky BW Adashi EY Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy Fertility and Sterility 63 3 1995 439 463
24. Dunaif A Insulin resistance and ovarian hyperandrogenism Endocrinologist 2 1992 248 260
25. Ehrmann DA Barnes RB Rosenfield RL Hyperandrogenism, hirsutism, and the polycystic ovary syndrome De Groot LJ Besser M Burger HG 3rd edn Endocrinology vol. 3 1994 WB Saunders Philadelphia 2093 2112
26. Ehrmann DA Barnes RB Rosenfield RL Polycystic ovary syndrome: a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion Endocrine Reviews 16 1995 322 353
27. El Tabbakh GH Lotfy I Azab I Correlation of the ultrasonic appearance of the ovaries in polycystic ovarian disease and the clinical, hormonal, and laparoscopic findings American Journal of Obstetrics and Gynecology 154 1986 892 895
28. Farquhar M Birdsall M Manning P The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women Australian and New Zealand Journal of Obstetrics and Gynaeology 34 1984 67
29. Fauser BCJM Pache TD Hop WCJ The significance of serum luteinizing hormone measurements in women with menstrual cycle disturbances: discrepancies between immunoreactive and bioactive hormone estimates Clinical Endocrinology 37 1992 445 452
30. Franks S Polycystic ovary syndrome: a changing perspective Clinical Endocrinology 1 1989 87 119
31. Franks S Polycystic ovary syndrome New England Journal of Medicine 333 1995 853 861
32. Futterweit W Kreiger DT Pituitary tumours associated with hyperprolactinaemia and polycystic ovarian disease Fertility and Sterility 31 1979 608 613
33. Givens JR Andersen RN Umstot ES Wiser WL Clinical findings and hormonal response in patients with polycystic ovarian disease with normal versus elevated LH levels Obstetrics and Gynecology 47 1976 388 394
34. Goldzieher MW Green JA The polycystic ovary. I. Clinical and histologic features Journal of Clinical Endocrinology and Metabolism 22 1962 325 338
35. Govan ADT Black WP Some observations on the histology of polycystic ovarian disease Coutts JRT Functional Morphology of the Human Ovary 1981 MTP Boston Press Limited 37 52
36. Hamilton-Fairley D Kiddy D Watson H Low-dose gonadotrophin therapy for induction of ovulation in 100 women with PCOS Human Reproduction 6 1991 1095 1099
37. Holte J Bergh T Berne C Lithell H Serum lipoprotein profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables Clinical Endocrinology 41 1994 463 472
38. Holte J Bergh T Gennarelli G Wide L The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women Clinical Endocrinology 41 1994 473 481
39. Hughesddon PE Morphology and morphogenesis of the Stein-Leventhal ovary and so called hyperthecosis Obstetric Gynecology Survey 37 1982 59 77
40. Kiddy DS Sharp PS White DM Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases Clinical Endocrinology 32 1990 213 220
41. Lapidus L Bengtsson C Larsson B Distribution of adipose tissue and risk of cardiovascular disease and death: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden British Medical Journal 289 1984 1257 1261
42. Lindstedt G Lundberg PA Lapidus L Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM Diabetes 40 1991 123 128
43. McKelgue P Are women with polycystic ovary syndrome at special risk for coronary heart disease? Clinical Endocrinology 37 1992 117 118
44. McKenna TJ Cunningham SK Adrenal androgen production in polycystic ovary syndrome European Journal of Endocrinology 133 1995 383 389
45. Nahum R Thong KJ Hillier SG Metabolic regulation of androgen production by human thecal cells in vitro Human Reproduction 1 1995 75 81
46. Nestler JE Regulation of human dehydroepiandrosterone metabolism by insulin Annals of the New York Academy of Science 774 1995 73 81
47. Nobels F Dewailly D Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis Fertility and Sterility 58 1992 655 666
48. Orsini LF Venturoli S Lorusso R Ultrasonic findings in polycystic ovarian disease Fertility and Sterility 43 1985 709 714
49. Pache TD Wladimiroff JW Hop WCJ Fauser BCJM How to discriminate between normal and polycystic ovaries: transvaginal US study Radiology 183 1992 421 423
50. Pasquali R Casimirri F The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women Clinical Endocrinology 39 1993 1 6
51. Pasquali R Casimirri F Venturoli D Body fat distribution has weight-independent effects on clinical, hormonal and metabolic features of women with polycystic ovary syndrome Metabolism 6 1994 706 713
52. Polson DW Adams J Wadsworth J Franks S Polycystic ovaries: a common finding in normal women Lancet i 1988 870 872
53. Reaven GM Pathophysiology of insulin resistance in human disease Physiological Review 75 1995 473 486
54. Reaven GM Lithell H Landsberg L Hypertension and associated metabolic abnormalities—the role of insulin resistance and the sympathoadrenal system New England Journal of Medicine 334 1996 374 381
55. Rebar R Judd HL Yen SCC Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome Journal of Clinical Investigation 57 1976 1320 1326
56. Rebuffe-Scrive M Cullberg G Lundberg PA Anthropometric variables and metabolism in polycystic ovarian disease Hormone and Metabolism Research 21 1989 391 397
57. Robert Y Dubrulle F Gaillandre G Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification Fertility and Sterility 64 1995 307 312
58. Rosenfield RL Evidence that idiopathic functional adrenal hyperandrogenism is caused by dysregulation of adrenal steroidogenesis and that hyperinsulinemia may be involved Journal of Clinical Endocrinology and Metabolism 81 3 1996 878 880
59. Secreto G Zumoff B Abnormal production of androgens in women with breast cancer Anticancer Research 14 1994 2113 2117
60. Sherman AI Brown S The precursors of endometrial carcinoma American Journal of Obstertic and Gynecology 135 1979 947 956
61. Soulez B Dewailly D Rosenfield RL Polycystic ovary syndrome: a multidisciplinary challenge Endocrinologist 6 1996 19 29
62. Stein IF Leventhal ML Amenorrhea associated with bilateral polycystic ovaries American Journal of Obstetric and Gynecology 29 1935 181 191
63. Stoll BA Vatten LJ Kvinnsland S Does early physical maturity influence breast cancer risk? Acta Oncology 33 1994 171 176
64. Suikkari AM MacLachlan V Montalto J Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment Human Reproduction 10 1995 513 519
65. White D Leigh A Wilson C Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome Clinical Endocrinology 42 5 1995 475 481
66. Yen SSC The polycystic ovary syndrome Clinical Endocrinology 12 1980 177 208
67. Zacur HA Foster GV Hyperprolactinemia and polycystic ovarian syndrome Seminary in Reproductive Endocrinology 10 1992 236 242